L-asparaginase exerts anti-leukemia activity.

被引:0
|
作者
Lu, Yuan [1 ]
Wang, Ling-zhen [1 ]
Zhong, Ren [1 ]
Sun, Li-rong [1 ]
Li, Xue-rong [1 ]
机构
[1] Qingdao Univ, Affiliated Hosp, Dept Pediat Hematol, Qingdao, Shandong, Peoples R China
来源
BIOMEDICAL RESEARCH-INDIA | 2017年 / 28卷 / 05期
关键词
L-ASP; Jurkat cells; Cell cycle; Geminin; ACUTE LYMPHOBLASTIC-LEUKEMIA; CELL-CYCLE ARREST; IN-VITRO; APOPTOSIS; SYNTHETASE; GEMININ; TUMORS; LINES;
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
This study aimed to investigate the effects of L-Asparaginase (L-ASP) on leukemia cell proliferation, cell cycle distribution and geminin expression. Jurkat cells were treated with different concentration of L-ASP for 24 h, 48 h or 72 h. Cell proliferation was analysed by the CCK-8 assay, cell cycle distribution was examined by flow cytometry, and mRNA and protein expression levels of geminin were assessed by PCR and Western blot analysis. The results showed that L-ASP inhibited the proliferation of Jurkat cells in a dose-and time-dependent manner. In addition, L-ASP at 0.5-10 U/ml induced G1 phase arrest of Jurkat cells. Geminin mRNA and protein expression remarkably decreased in Jurkat cells treated with L-ASP at 1.0-10 U/ml. In conclusion, our study suggests that the anti-leukemia mechanism of L-ASP is related to the arrest of leukemia cells in G1 phase and the downregulation of geminin expression.
引用
收藏
页码:1988 / 1991
页数:4
相关论文
共 50 条
  • [31] Experience with generic pegylated L-asparaginase in children with acute lymphoblastic leukemia and monitoring of serum asparaginase activity
    Vyas, Chintan
    Jain, Sandeep
    Kapoor, Gauri
    Mehta, Anurag
    Chugh, Parul Takkar
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2018, 35 (5-6) : 331 - 340
  • [32] IMMUNOCHEMICAL CHARACTERIZATION OF ANTI L-ASPARAGINASE IMMUNOGLOBULIN
    DEBARIER.A
    MISTRETTA, AP
    TASSI, GC
    BOLLETTINO DELLA SOCIETA ITALIANA DI BIOLOGIA SPERIMENTALE, 1971, 47 (3-4): : 98 - +
  • [33] L-ASPARAGINASE
    CAPIZZI, RL
    BERTINO, JR
    HANDSCHUMACHER, RE
    ANNUAL REVIEW OF MEDICINE, 1970, 21 : 433 - +
  • [34] POLYETHYLENE-GLYCOL L-ASPARAGINASE AND L-ASPARAGINASE STUDIES
    HO, DHW
    LIN, JR
    BROWN, N
    COVINGTON, W
    NEWMAN, RA
    KRAKOFF, IH
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 419 - 419
  • [35] Investigating the Potential Use of L-Asparaginase in Myeloid Leukemia
    Jun, Sung Ah
    Sepiashvili, Lusia
    Kislinger, Thomas
    Minden, Mark D.
    BLOOD, 2011, 118 (21) : 1555 - 1555
  • [36] L-ASPARAGINASE COMBINATION THERAPY OF CHILDHOOD ACUTE LEUKEMIA
    HAGHBIN, M
    TAN, C
    TALLAL, L
    WOLLNER, N
    ROSENSTOCK, J
    BURCHENAL, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1970, 11 : 33 - +
  • [37] Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia
    Narta, Umesh K.
    Kanwar, Shamsher S.
    Azmi, Wamik
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 61 (03) : 208 - 221
  • [38] Adipocytes Cause Leukemia Cell Resistance to L-Asparaginase
    Ehsampour, Ehsan A.
    Behan, Jim W.
    Avramis, Vassilios I.
    Mittelman, Steven D.
    OBESITY, 2009, 17 : S98 - S99
  • [39] INHIBITION OF LYMPHOCYTE TRANSFORMATION BY L-ASPARAGINASE IN ACUTE LEUKEMIA
    GIRAUDOCONESA, LC
    SCORNIK, JC
    PAVLOVSKY, S
    MEDICINA, 1971, 31 (05): : 434 - +
  • [40] L-asparaginase in the treatment of patients with acute lymphoblastic leukemia
    Egler, Rachel A.
    Ahuja, Sanjay P.
    Matloub, Yousif
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2016, 7 (02) : 62 - 71